Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,135.06
(
-0.04%
)
US TECH 100
26,215.20
(
0.04%
)
Dow Jones
49,415.22
(
-0.15%
)
Brent Oil
98.95
(
2.30%
)
Bitcoin
78,350.01
(
0.14%
)
News Focus
News Focus

Replies to post #141967 on Biotech Values

Replies to #141967 on Biotech Values
icon url

masterlongevity

05/15/12 11:12 PM

#142003 RE: DewDiligence #141967

this was a genentech deal, and crenezumab is still controlled by Genentech. It is in the GRED early development group, which is said to have little to no Roche influence.